ClinicalTrials.Veeva

Menu

Ambulatory CPAP Titration in Moderate Obstructive Sleep Apnea (ATMOS)

U

Universitaire Ziekenhuizen KU Leuven

Status

Completed

Conditions

Sleep Apnea, Obstructive

Treatments

Device: PAP titration at home

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this trial is to compare two different ways of CPAP titration:

CAP titration with fixed pressure vs. auto-titrating CPAP.

Full description

Continuous positive airway pressure (CPAP) for the treatment of moderate obstructive sleep apnea (OSA) is only reimbursed in Belgium after in-laboratory overnight titration. Nevertheless, in a recent clinical practice guideline of the AASM, it is recommended that PAP therapy can be initiated using either in-laboratory titration or auto-titrating CPAP (APAP) at home in OSA patients without significant comorbidities. Indeed, several studies evaluated the impact of titration with APAP at home in these patients and showed that the outcome is comparable with in-hospital titration. Up to now, evidence for home titration with fixed CPAP (and follow-up via telemonitoring) is very limited. The use of sleep laboratory space is costly and limits access for diagnostic studies. This study aims to evaluate whether CPAP titration at home with fixed CPAP produces outcomes equal to those following APAP titration.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • moderate OSA (obstructive AHI 15-30/u on initial PSG)

Exclusion criteria

  • Presence of hypoventilation
  • Presence of central sleep apnea (central AHI ≥ 15)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Fixed CPAP titration at home
Experimental group
Description:
Patients will start CPAP treatment with a pressure that is calculated by the following formula (predicted pressure = (0.13 x BMI) + (0.16x neck circumference in cm) + (0.04 x AHI)) with a maximal pressure of 10 cmH2O. After 3 nights and after 7 nights, CPAP data will be remotely evaluated and pressure will be adapted based on the following rules: * After 3 nights: median obstructive AHI\<5/h: decrease pressure with 2 cmH2O; median obstructive AHI\>5/h: increase with 2cmH2O * After 7 nights: median obstructive AHI\>5/h of 4 nights after last adaptation: increase with 2 cmH2O
Treatment:
Device: PAP titration at home
APAP titration at home
Active Comparator group
Description:
Patients will start CPAP treatment with an auto-adjusting CPAP device with pressure levels between 4 and 12 cmH2O. After 7 nights of titration, the optimal pressure will be determined by analyzing the median of the nightly pressure that included 95% of the periods (percentile 95). CPAP treatment will be continued with this fixed optimal pressure.
Treatment:
Device: PAP titration at home

Trial contacts and locations

1

Loading...

Central trial contact

Dries Testelmans, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems